叶酸-PEG-PROTAC小胞子用于增强体内瘤特异性向蛋白解
Junhui Ma1, Lei Fang1, Zhengjun Sun1
1Department of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Advanced healthcare materials
|April 27, 2024
概括
这项研究引入了针对蛋白质溶解向金马 (PROTACs) 的自我组装细胞,以增强癌症治疗. 这些新型的PROTAC小鼠可以改善瘤向和抗瘤疗效.
科学领域:
- 生物化学 生物化学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 在癌症治疗中,蛋白质分解向嵌合体 (PROTACs) 为向蛋白质降解提供了一个新的策略.
- 目前的PROTAC应用受限于诸如高分子量,低生物利用性和不足的体内疗效等问题.
研究的目的:
- 为了设计可自组装的叶酸-聚乙烯糖醇-PROTAC (FA-PEG-PROTAC) 微粒,用于选择性向癌细胞.
- 为了评估这些FA-PEG-PROTAC小粒在减少性瘤微环境中的有效性,以增强癌症治疗.
主要方法:
- FA-PEG-PROTAC是通过通过二硫化键将叶酸-PEG与以EGFR为向的PROTAC结合合成的.
- 从FA-PEG-PROTAC中形成了自我组装的菌体.
- 在老鼠异种移植模型中测试了细胞的有效性.
主要成果:
- 与传统的PROTAC相比,FA-PEG-PROTAC小粒显示出更好的瘤向疗效.
- 在老鼠异种移植模型中,菌体表现出显著的抗瘤疗效.
- 自组装策略提高了目标蛋白解效率.
结论:
- 自组装的FA-PEG-PROTAC小组体代表了克服传统PROTACs局限性的有希望的方法.
- 这一策略改善了向蛋白解,并有可能在基于PROTAC的癌症治疗药物开发中得到更广泛的应用.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


